These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 37889357)

  • 1. Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity.
    Liu S; Fang C; Zhong C; Li J; Xiao Q
    Cell Biol Toxicol; 2023 Dec; 39(6):2527-2549. PubMed ID: 37889357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.
    Andrysiak K; Stępniewski J; Dulak J
    Pflugers Arch; 2021 Jul; 473(7):1061-1085. PubMed ID: 33629131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi-lineage heart-chip models drug cardiotoxicity and enhances maturation of human stem cell-derived cardiovascular cells.
    Mozneb M; Jenkins A; Sances S; Pohlman S; Workman MJ; West D; Ondatje B; El-Ghazawi K; Woodbury A; Garcia VJ; Patel S; Arzt M; Dezem F; Laperle AH; Moser VA; Ho R; Yucer N; Plummer J; Barrett RJ; Svendsen CN; Sharma A
    Lab Chip; 2024 Feb; 24(4):869-881. PubMed ID: 38252454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity.
    Weng KC; Kurokawa YK; Hajek BS; Paladin JA; Shirure VS; George SC
    Tissue Eng Part C Methods; 2020 Jan; 26(1):44-55. PubMed ID: 31797733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concise Review: Precision Matchmaking: Induced Pluripotent Stem Cells Meet Cardio-Oncology.
    Nair P; Prado M; Perea-Gil I; Karakikes I
    Stem Cells Transl Med; 2019 Aug; 8(8):758-767. PubMed ID: 31020786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular Toxicity in Cancer Therapy: Protecting the Heart while Combating Cancer.
    Manhas A; Tripathi D; Thomas D; Sayed N
    Curr Cardiol Rep; 2024 Sep; 26(9):953-971. PubMed ID: 39042344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
    Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
    Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of In Vitro Drug-Induced Cardiotoxicity Assay by Using Three-Dimensional Cardiac Tissues Derived from Human Induced Pluripotent Stem Cells.
    Takeda M; Miyagawa S; Fukushima S; Saito A; Ito E; Harada A; Matsuura R; Iseoka H; Sougawa N; Mochizuki-Oda N; Matsusaki M; Akashi M; Sawa Y
    Tissue Eng Part C Methods; 2018 Jan; 24(1):56-67. PubMed ID: 28967302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular model systems to study cardiovascular injury from chemotherapy.
    Fonoudi H; Burridge PW
    J Thromb Thrombolysis; 2021 May; 51(4):890-896. PubMed ID: 33051807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Induced Pluripotent Stem Cell (hiPSC)-Derived Cells to Assess Drug Cardiotoxicity: Opportunities and Problems.
    Magdy T; Schuldt AJT; Wu JC; Bernstein D; Burridge PW
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():83-103. PubMed ID: 28992430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HiPSC-derived multi-organoids-on-chip system for safety assessment of antidepressant drugs.
    Yin F; Zhang X; Wang L; Wang Y; Zhu Y; Li Z; Tao T; Chen W; Yu H; Qin J
    Lab Chip; 2021 Feb; 21(3):571-581. PubMed ID: 33319899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs.
    Sachinidis A
    Cells; 2020 Apr; 9(4):. PubMed ID: 32316481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and maturation of human iPSC-derived 3D organotypic cardiac microtissues in long-term culture.
    Ergir E; Oliver-De La Cruz J; Fernandes S; Cassani M; Niro F; Pereira-Sousa D; Vrbský J; Vinarský V; Perestrelo AR; Debellis D; Vadovičová N; Uldrijan S; Cavalieri F; Pagliari S; Redl H; Ertl P; Forte G
    Sci Rep; 2022 Oct; 12(1):17409. PubMed ID: 36257968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pluripotent Stem Cell Modeling of Anticancer Therapy-Induced Cardiotoxicity.
    Lyra-Leite DM; Burridge PW
    Curr Cardiol Rep; 2020 Jun; 22(8):56. PubMed ID: 32562096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Cardiotoxicity Assays Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes (hiPSC-CMs).
    Narkar A; Willard JM; Blinova K
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells.
    Sharma A; Burridge PW; McKeithan WL; Serrano R; Shukla P; Sayed N; Churko JM; Kitani T; Wu H; Holmström A; Matsa E; Zhang Y; Kumar A; Fan AC; Del Álamo JC; Wu SM; Moslehi JJ; Mercola M; Wu JC
    Sci Transl Med; 2017 Feb; 9(377):. PubMed ID: 28202772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposal for considerations during human iPSC-derived cardiac organoid generation for cardiotoxicity drug testing.
    Lee SW; Song M; Woo DH; Jeong GS
    Biomed Pharmacother; 2024 May; 174():116511. PubMed ID: 38574616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prediction of Cardiac Toxicity by Anti-cancer Drugs Using iPSC Cardiomyocytes].
    Yanagida S; Kanda Y
    Yakugaku Zasshi; 2024; 144(3):265-271. PubMed ID: 38432935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalized medicine in cardio-oncology: the role of induced pluripotent stem cell.
    Sayed N; Ameen M; Wu JC
    Cardiovasc Res; 2019 Apr; 115(5):949-959. PubMed ID: 30768178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.